1. Chinese State Council. 74 drugs to be added to national insurance list. 2021. http://english.www.gov.cn/statecouncil/ministries/202112/07/content_WS61aeb805c6d09c94e48a1cbd.html
2. Technology Development Center of Chinese Pharmaceutical Association . Blue book on progress and achievement of medical insurance reform in China. CPA, 2021.
3. Chinese State Council. Over 60 rare-disease drugs approved for Chinese market. 2021. https://english.www.gov.cn/statecouncil/ministries/202112/19/content_WS61be7078c6d09c94e48a26d9.html
4. Analysis on the current situation of listed innovative drugs in China from 2017 to 2020;Tang;World Clinical Drugs,2022
5. Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China